Beta Bionics, Inc.
BBNX
$15.02
$0.030.20%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
3/11/2025
-
MarketBeat
3/10/2025
-
Ticker Report
3/6/2025
-
MarketBeat
3/5/2025
-
MarketBeat
3/4/2025
-
MarketBeat
3/3/2025
-
Insider Monkey
2/27/2025
-
GuruFocus
2/27/2025
-
Globe Newswire
2/26/2025
-
MarketBeat
2/25/2025
-
MarketBeat
2/24/2025
-
MarketBeat
2/24/2025
-
TipRanks Financial Blog
2/24/2025
-
The Fly
2/24/2025
-
MarketBeat
2/24/2025
-
MarketBeat
2/24/2025
-
The Fly
2/24/2025
-
MarketBeat
2/24/2025
-
MarketBeat
2/24/2025
-
MarketBeat
2/24/2025
-
The Fly
2/24/2025
-
TipRanks Financial Blog
2/24/2025
-
The Fly
2/24/2025
-
The Fly
2/22/2025
-
MarketBeat
2/21/2025
-
MarketBeat
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
--
Net Income (TTM)
--
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
--
Cash from Investing (TTM)
--
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
--
Filings
Filing Date
Friday, January 31, 2025
Period Date
Monday, September 30, 2024
Next Filing
Week of Jan 26 and 30 (est)
Price History
Beta
--
7-Day Total Return
30-Day Total Return
--
60-Day Total Return
--
90-Day Total Return
--
Year to Date Total Return
1-Year Total Return
--
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
949 427 7785
Address
11 Hughes
Irvine, CA 92618
Irvine, CA 92618
Country
Year Founded
Business Description
Sector
Industry
Beta Bionics, Inc., a commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and quality of life of...
more
